Cathie Wood 购买 780 万美元的 Moderna 疫苗股票，押注多元化管道和监管胜利

周二，Cathie Wood 的 Ark Invest 大幅增持了著名的 COVID-19 疫苗制造商 Moderna Inc. (MRNA) 的股份，原因是这家生物技术公司即将迎来一系列催化剂。 Ark Invest 通过其旗舰 Ark Innovation ETF (ARKK) 购买了 72,800 股 Moderna 股票，价值约 782 万美元。此举表明 Ark Invest 对 Moderna 除了 mRNA COVID-19 疫苗之外的潜力继续充满信心，包括下一代 COVID-19 疫苗和其他有前途的候选疫苗。

Why Cathie Wood Just Bought $7.8 Million Worth of This COVID-19 Vaccine Stock

为什么 Cathie Wood 刚刚购买了价值 780 万美元的这种 COVID-19 疫苗股票

Embracing a "buy the dip" mentality, Cathie Wood's Ark Invest has significantly boosted its stake in Moderna Inc., a leading COVID-19 vaccine producer, with a strategic purchase of 72,800 shares. Priced at $107.41 each, this acquisition represents an investment of approximately $7.82 million.

Cathie Wood 的 Ark Invest 秉承“逢低买入”的心态，大幅增持了领先的 COVID-19 疫苗生产商 Moderna Inc. 的股份，战略性购买了 72,800 股。此次收购的单价为 107.41 美元，投资额约为 782 万美元。

Betting on Moderna's Diversified Pipeline

押注 Moderna 的多元化产品线

Ark Invest's enthusiasm for Moderna extends beyond the firm's mRNA COVID-19 vaccine. The investment firm sees immense potential in Moderna's broader pipeline, including a next-generation COVID-19 vaccine and promising candidates in various therapeutic areas.

Ark Invest 对 Moderna 的热情不仅限于该公司的 mRNA COVID-19 疫苗。该投资公司看到了 Moderna 更广泛的产品线的巨大潜力，包括下一代 COVID-19 疫苗和各个治疗领域有前途的候选疫苗。

Riding the Regulatory Wave

驾驭监管浪潮

With expectations of vaccine approvals and upcoming investor events, Ark Invest anticipates Moderna's stock to soar despite its recent market underperformance. Moderna's stock has declined by 26.89% over the past 12 months, but has rebounded by 8% since the start of 2024.

由于对疫苗批准和即将举行的投资者活动的预期，Ark Invest 预计 Moderna 的股价将飙升，尽管其近期市场表现不佳。 Moderna 的股价在过去 12 个月内下跌了 26.89%，但自 2024 年初以来已反弹 8%。

Other Notable Trades

其他值得注意的交易

In addition to the Moderna purchase, ARKG, Ark's genomic revolution ETF, has shed 1,770 shares of Nvidia Corp. Valued at $1.63 million, this move signals a shift in focus within the ETF's portfolio.

除了收购 Moderna 之外，Ark 的基因组革命 ETF ARKG 还出售了 1,770 股 Nvidia 公司股票。价值 163 万美元，此举标志着 ETF 投资组合的重点发生了转变。

Meanwhile, ARKF, Ark's fintech innovation ETF, has acquired shares of Roblox Corp., while ARKG has expanded its holdings in Recursion Pharmaceuticals with a purchase of 60,9626 shares. On the other hand, ARKQ, Ark's autonomous technology and robotics ETF, has sold shares of Trimble Inc.

与此同时，Ark 的金融科技创新 ETF ARKF 收购了 Roblox Corp. 的股份，而 ARKG 则通过购买 60,9626 股扩大了 Recursion Pharmaceuticals 的持股。另一方面，Ark的自主技术和机器人ETF ARKQ已出售Trimble Inc.的股票。